Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trialElias Jabbour, Hagop M. Kantarjian, Zhaohui Gu et al.|The Lancet Haematology|2020Cited by 64
Hyper-CVAD and Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Results from a Phase II StudyNicholas J. Short, Elias Jabbour, Hagop M. Kantarjian et al.|Blood|2020Cited by 20
Frontline Therapy for Older Patients (pts) with Acute Myeloid Leukemia (AML): Clofarabine Plus Low-Dose Cytarabine Induction Followed by Prolonged Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with DecitabineStefan Faderl, Hagop M. Kantarjian, Farhad Ravandi et al.|Blood|2010Cited by 13